New Combo KOs HCV Without Interferon, Ribavirin - MedPage Today
Los Angeles TimesNew Combo KOs HCV Without Interferon, RibavirinMedPage TodayAll of the patients had previously failed standard therapy with pegylated interferon and ribavirin, Lok and colleagues reported in the Jan.
New Study Hailed as 'Watershed Moment' in Hep C Research - Infectious Disease Special Edition
Infectious Disease Special EditionNew Study Hailed as 'Watershed Moment' in Hep C ResearchInfectious Disease Special EditionSuccess rates were 100% in patients who received the drugs in combination with peginterferon alfa-2a (Peg-IFN) and ribavirin (RBV).
Merck Warns of Victrelis and HIV Protease Inhibitor Interactions - AIDSmeds.com HIV/AIDS Treatment News
Merck Warns of Victrelis and HIV Protease Inhibitor InteractionsAIDSmeds.
Gilead Woes With New Hep C Data, Boxing Out Poor 2012 Guidance - TheStreet.com
RTT NewsGilead Woes With New Hep C Data, Boxing Out Poor 2012 GuidanceTheStreet.
Aethlon Medical to Present Hepatitis C (HCV) Treatment Technology at the 32nd ... - MarketWatch (press release)
Aethlon Medical to Present Hepatitis C (HCV) Treatment Technology at the 32nd .